The top biotech stories of 2016
Biotech has been very hot this year as one of the fastest growing tech sectors as costs have plummeted, allowing innovation to speed up and bring us exciting innovations in health. But it’s been a bit of a rollercoaster ride for investors.
The many Theranos scandals became a primer on what not to do when building a billion-dollar biotech startup and then we had exciting IPOs (and a giant lawsuit) from some CRISPR-focused companies like Editas and Intellia. Here we outline the many ups and downs of the industry in 2016. So strap in and grab your microscopes for this bumpy ride in the year of biotech.